Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma

Lack of remission or early relapse remains a major clinical issue in diffuse large B-cell lymphoma (DLBCL), with 30% of patients failing standard of care. Although clinical factors and molecular signatures can partially predict DLBCL outcome, additional information is needed to identify high-risk pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, A J, Asmann, Y W, Maurer, M J, Wang, C, Slager, S L, Hodge, L S, Manske, M, Price-Troska, T, Yang, Z-Z, Zimmermann, M T, Nowakowski, G S, Ansell, S M, Witzig, T E, McPhail, E, Ketterling, R, Feldman, A L, Dogan, A, Link, B K, Habermann, T M, Cerhan, J R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558593/
https://www.ncbi.nlm.nih.gov/pubmed/26314988
http://dx.doi.org/10.1038/bcj.2015.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558593/
https://www.ncbi.nlm.nih.gov/pubmed/26314988
http://dx.doi.org/10.1038/bcj.2015.69

Ejemplares similares